Effect of lipopolysaccharide on P-glycoprotein-mediated intestinal and biliary excretion of rhodamine123 in rats

International Journal of Pharmaceutics

Volumn 392, Issue 1-2, 2010, Pages 35-41

  Tomita, Mikio ^a   Kanbayashi, Atsushi ^a   Murata, Hiroyuki ^a   Tanaka, Ayako ^a   Nakaike, Mariko ^a   Hatanaka, Megumi ^a   Hayashi, Masahiro ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Inducible nitric oxide synthesis (iNOS); Interleukin 1 (IL 1 ); Intestine; Lipopolysaccharide; Liver; P glycoprotein mediated transport

Indexed keywords

GLYCOPROTEIN P; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1A; RHODAMINE 123; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; GENE EXPRESSION; ILEUM; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT;

ANIMALS; BILE; BLOTTING, WESTERN; GENE EXPRESSION; ILEUM; LIPOPOLYSACCHARIDES; LIVER; MALE; METABOLIC DETOXICATION, DRUG; P-GLYCOPROTEINS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODAMINE 123;

EID: 77952740971     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.03.019     Document Type: Article

References (35)

1. Chapekar M.G., Huggett A.C., Cheng C. Dexamethasone prevents the growth inhibitory effects of recombinant tumor necrosis factor in a rat hepatoma cell line Reuber-RC-3: an association with the changes in the messenger RNA levels for multidrug resistance gene. Biochem. Biophys. Res. Commun. 1991, 181:1524-1531.
2. Chin J.E., Soffir R., Noonan K.E., Choi K., Roninson L.B. Structure and expression of the human MDR (P-glycoprotein) gene family. Mol. Cell Biol. 1989, 9:3808-3820.
3. de Lange E.C., de Bock G., Schinkel A.H., de Boer A.G., Breimer D.D. BBB transport and P-glycoprotein functionality using mdr1a (-/-) and wild-type mice. Total brain versus microdialysis concentration profiles of rhodamine-123. Pharm. Res. 1998, 15:1657-1665.
4. Fojo A.T., Ueda K., Slamon D.J., Poplack D.G., Gottesman M.M., Pastan L. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:265-269.
5. Haghgoo S., Hasegawa H., Nadai M., Wang L., Nabeshima T., Kato N. Effect of a bacterial lipopolysaccharide on biliary excretion of a 3-lactam antibiotic, cefoperazone, in rats. Antimicrob. Agents Chemother. 1995, 39:2258-2261.
6. Hasegawa T., Ohta M., Mori M., Nakashima I., Kato N., Morikawa K., Hanada T., Okuyama T. Structure of polysaccharide moiety of Klebsiella O3 lipopolysaccharide isolated from culture supernatant of decapsulated mutant (Klebsiella O3:K1-). Chem. Pharm. Bull. 1985, 33:333-339.
7. Hirsch-Ernst K.I., Ziemann C., Foth H., Kozian D., Schmitz-Salue C., Kahl G.F. Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures. J. Cell Physiol. 1998, 176:506-515.
8. Hsing S., Gatmaitan Z., Arias I.M. The function of Gp170, the multidrug-resistance gene product, in the brush border of rat intestinal mucosa. Gastroenterology 1992, 102:879-885.
9. Ito K., Suzuki H., Hirohashi T., Kume K., Shimizu T., Sugiyama Y. Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR. Am. J. Physiol. 1997, 272:G16-G22.
10. Kamimoto Y., Gatmaitan Z., Hsu J., Arias I.M. The function of Gp170, the multidrug-resistance gene product, in rat liver canalicular membrane vesicles. J. Biol. Chem. 1989, 264:11693-11698.
11. Kiso S., Cai S.H., Kitaichi K., Furui N., Takagi K., Takagi K., Nabeshima T., Hasegawa T. Inhibitory effect of erythromycin on P-glycoprotein-mediated biliary excretion of doxorubicin in rats. Anticancer Res. 2000, 20:2827-2834.
12. Kitaichi K., Wang L., Takagi K., Iwase M., Shibata E., Nadai M., Takagi K., Hasegawa T. Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide. Antimicrob. Agents Chemother. 1999, 43:2697-2701.
13. Kunihara M., Nagai J., Murakami T., Takano M. Renal excretion of rhodamine-123, a P-glycoprotein substrate, in rats with glycerol-induced acute renal failure. J. Pharm. Pharmacol. 1998, 50:1161-1165.
14. Lee J.S., Paull K., Alvarez M., Hose C., Monks A., Grever M., Fojo A.T., Bates S.E. Rhodamine efflux patterns predict P-glycoprotein substrates in the national cancer institute drug screen. Mol. Pharmacol. 1994, 46:627-638.
15. Mayer R., Kartenbeck J., Buchler M., Jedlitschky G., Leier I., Kuppler D. Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes. J. Cell Biol. 1995, 131:137-150.
16. Nadai M., Hasegawa T., Wang L., Haghgoo S., Okasaka T., Nabeshima T., Kato N. Alterations in renal uptake kinetics of the xanthine derivative enprofylline in endotoxaemic mice. J. Pharm. Pharmacol. 1996, 48:744-748.
17. Nagira M., Tomita M., Mizuno S., Kumata M., Ayabe T., Hayashi M. Ischemia/reperfusion injury in the monolayers of human intestinal epithelial cell line caco-2 and its recovery by antioxidant. Drug Metab. Pharmacokinet. 2006, 21:230-237.
18. Nakamura J., Nishida T., Hayashi K., Kawada N., Ueshima S., Sugiyama Y., Ito T., Sobue K., Matsuda H. Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression. Biochem. Biophys. Res. Commun. 1999, 255:143-149.
19. Neyfakh A.A., Srpinskaya A.S., Chervonsky A.V., Apasov S.G., Kazarov A.R. Multidrug-resistance phenotype of a subpopulation of T-lymphocytes without drug selection. Exp. Cell Res. 1989, 185:496-505.
20. Oude, Elferink R.P., Meijer D.K., Kuipers F., Jansen P.L., Groen A.K., Groothuis G.M. Hepatobiliary secretion of organic compounds: molecular mechanisms of membrane transport. Biochim. Biophys. Acta 1995, 1241:215-268.
21. Roelofsen H., Schomaker B., Bakker C., Ottenhoff R., Jansen P.L., Elferink R.P. Impaired hepatocanalicular organic anion transporter in endotoxemic rats. Am. J. Physiol. 1995, 269:G427-G434.
22. Schinkel A.H., Smit J.J., van Tellingen O., Beijnen J.H., Wagenaar E., van Deemter L., Mol C.A., van der Valk M., Robanus-Maandag E.C., te Riele H.P., Bermas A.J.M., Borst P. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 1994, 77:491-502.
23. Stein U., Walther W., Laurencot C.M., Scheffer G.L., Scheper R.J., Shoemaker R.H. Tumor necrosis factor-a and expression of the multidrug resistance-associated genes LRP and MRP. J. Natl. Cancer Inst. 1997, 89:807-813.
24. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastn I., Willingham M.C. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:7735-7738.
25. Tomita M., Takizawa Y., Kishimoto H., Hayashi M. Effect of intestinal ischemia/reperfusion on P-glycoprotein mediated ileal excretion of rhodaimne123 in rat. J. Pharm. Pharmacol. 2009, 61:1319-1324.
26. Tomita M., Kishimoto H., Takizawa Y., Hayashi M. Effect of intestinal ischemia/reperfusion on P-glycoprotein mediated biliary and renal excretion of rhodaimne123 in rat. Drug Metab. Pharmacokinet. 2009, 24:428-437.
27. Tomita M., Menconi M.J., Delude R.L., Fink M.P. Polarized transport of hydrophilic compounds across rat colonic mucosa from serosa to mucosa is temperature dependent. Gastroenterology 2000, 118:535-543.
28. Tomita M., Takizawa Y., Kishimoto H., Hayashi M. Assessment of ileal epithelial P-glycoprotein dysfunction induced by ischemia/reperfusion using in vivo animal model. Drug Metab. Pharmacokinet. 2008, 23:356-363.
29. Tsuruo T., Iida H., Tsukagoshi S., Sakurai Y. Increased accumulation of vincristine and adriamycin in drug-resistant tumor cells following incubation with calcium antagonists and calmodulin inhibitors. Cancer Res. 1982, 42:4730-4733.
30. Twentyman P.R., Fox N.E., White D.J. Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multidrug resistant human lung cancer cell line. Br. J. Cancer 1987, 56:55-57.
31. van Asperen J., van Tellingen O., Beijnen J.H. The role of mdr1a P-glycoprotein in the biliary and intestinal secretion of doxorubicin and vinblastine in mice. Drug Metab. Dispos. 2000, 28:264-267.
32. Wacher V.J., Wu C.-Y., Benet L.Z. Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog. 1995, 13:129-134.
33. Wang Q., Kitaichi K., Cai S.H., Takagi K., Takagi K., Sakai M., Yokogawa K., Miyamoto K.I., Hasegawa T. A reversal of anticancer drug resistance by macrolide antibiotics in vitro and in vivo. Clin. Exp. Pharmacol. Physiol. 2000, 27:587-593.
34. Wang Q., Yang H., Miller D.W., Elmquist W.F. Effect of the P-glycoprotein inhibitor, cyclosporine A, on the distribution of rhodamine-123 to the brain: an in vivo microdialysis study in freely moving rats. Biochem. Biophys. Res. Commun. 1995, 211:719-726.
35. Yamashita S., Saitoh H., Nakanishi K., Masada M., Nadai T., Kimura T. Effects of diclofenac sodium and disodium ethylenediaminetetraacetate on electrical parameters of the mucosal membrane and their relation to the permeability enhancing effects in the rat jejunum. J. Pharm. Pharmacol. 1987, 39:621-622.